Research demonstrates a double-acting mechanism for fighting triple-negative breast cancer

Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has published a new paper in the journal Nature Cancer.

FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases – Pharmaceutical Technology

The FDA adjusted the risk of the medicine after identifying 82 cases worldwide from 1996 to 2024. Image credit: Shutterstock / Jeppe Gustafsson. The US

January 23, 2025

Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

March 29, 2024

New MECP2 gene variant identified and characterized in Rett syndrome

Rett syndrome is a rare devastating neurological disorder that primarily affects young girls and manifests as an impaired ability to walk and talk, along with

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.